Marc Garidel is the founder of CinCor Pharma. CinCor Pharma has raised $400M in total funding. Latest round: IPO. Based in San Diego, California.
Marc de Garidel is the Chief Executive Officer and a board member of CinCor Pharma, a clinical-stage biopharmaceutical company. He led the company through significant funding rounds, including a $50 million Series A and a combined Series B and IPO raising approximately $200 million. CinCor was eventually acquired by AstraZeneca for an estimated $1.3 billion plus up to $500 million in milestones.
Full founder directory · Investor directory · Company funding database · Fundraising library